Last update 24 Jan 2025
Shaanxi Micot Technology Co., Ltd.

Shaanxi Micot Technology Co., Ltd.

Private Company|
2007|
Shaanxi Sheng, China
|
www.micot.cn

Overview

Basic Info

Introduction
Shaanxi Micot Technology Co., Ltd. is a privately-owned enterprise based in China that specializes in researching, developing, and producing pharmaceutical products for the treatment of cardiovascular, metabolic, and liver diseases.

Tags

Endocrinology and Metabolic Disease
Cardiovascular Diseases
Nervous System Diseases
Synthetic peptide
Biological products
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease5
Nervous System Diseases3
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Synthetic peptide10
Biological products1
Small molecule drug1
Top 5 TargetCount
GP IIb/IIIa(Integrin alpha-IIb/beta-3)1
PTH1R(Parathyroid hormone receptor)1
FXR(Bile acid receptor FXR)1
GP IIb/IIIa x thrombin1

Related

12
Drugs associated with Shaanxi Micot Technology Co., Ltd.
MT-1013
Target
PTH1R
Mechanism
PTH1R antagonists
Active Org.
Shaanxi Micot Technology Co., Ltd.Shaanxi Micot Technology Co., Ltd.
Originator Org.
Shaanxi Micot Technology Co., Ltd.Shaanxi Micot Technology Co., Ltd.
Active Indication
Hyperparathyroidism, Secondary [+2]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Pury Peptide
Target
GP IIb/IIIa
Mechanism
GP IIb/IIIa antagonists
Active Org.
Shaanxi Micot Technology Co., Ltd.Shaanxi Micot Technology Co., Ltd.
Originator Org.
Shaanxi Micot Technology Co., Ltd.Shaanxi Micot Technology Co., Ltd.
Active Indication
Acute Coronary Syndrome
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
MT-1002
Target
GP IIb/IIIa x thrombin
Mechanism
GP IIb/IIIa antagonists [+1]
Active Org.
Shaanxi Micot Technology Co., Ltd.Shaanxi Micot Technology Co., Ltd.
Originator Org.
Shaanxi Micot Technology Co., Ltd.Shaanxi Micot Technology Co., Ltd.
Active Indication
Acute Coronary Syndrome [+4]
Inactive Indication
Acrocallosal Syndrome [+3]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
20
Clinical Trials associated with Shaanxi Micot Technology Co., Ltd.
NCT06690242
/ RecruitingPhase 2
A Multicenter, Randomized, Single Blind, Positive Controlled, and Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of MT1013 Injection in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Undergoing Maintenance Hemodialysis
CTR20243499
/ RecruitingPhase 2
评价注射用 MT1013 治疗接受维持性血液透析的慢性肾脏病伴发继发性甲状旁腺功能亢进受试者的有效性和安全性的多中心、随机、单盲、阳性对照及安慰剂对照的 II 期临床研究
[Translation] A multicenter, randomized, single-blind, positive-controlled and placebo-controlled Phase II clinical study to evaluate the efficacy and safety of MT1013 for injection in the treatment of chronic kidney disease with secondary hyperparathyroidism in subjects receiving maintenance hemodialysis
CTR20241598
/ RecruitingPhase 2
评价注射用 MT1013 治疗接受维持性血液透析的慢性肾脏病伴发继发性甲状旁腺功能亢进患者的安全性和有效性的多中心、开放、单臂 Ⅱb 期临床研究
[Translation] A multicenter, open-label, single-arm Phase IIb clinical study to evaluate the safety and efficacy of MT1013 for injection in the treatment of patients with chronic kidney disease and secondary hyperparathyroidism receiving maintenance hemodialysis
100 Clinical Results associated with Shaanxi Micot Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shaanxi Micot Technology Co., Ltd.
Login to view more data
100 Deals associated with Shaanxi Micot Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shaanxi Micot Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
4
1
IND Application
Phase 1
3
3
Phase 2
Phase 3
1
14
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free